Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery

ConditionCardiac Valve Disease

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age20-75

SponsorKonkuk University Medical Center

About this trial

The primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for cardiac surgery.

Eligibility criteria

Qualifiers

patients undergoing cardiac surgery

Disqualifiers

thrombocytopenia

oral anti-coagulant

anti platelet agents

Trial design

Treatments tested in this trial

fresh frozen plasma
prothrombin complex concentrate

Treatment groups

100 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Konkuk University Medical Center

Lead sponsor

Asan Medical Center

Collaborator

Soonchunhyang University Hospital

Collaborator

Source ClinicalTrials.gov